Clinical Trial Update: Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial. [Phase 2]

View source ↗

Summary

Phase II multicentre trial evaluating nab-paclitaxel plus cisplatin with concurrent radiotherapy for locally advanced cervical cancer (not yet recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Cervical Cancer | Phase 2 | Status: NOT_YET_RECRUITING